Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmonx CorpLUNG · Entity 2359 | Chief Commercial Officer | September 01, 2026 | September 03, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmonx Corp
Report date September 01, 2026 · Filed September 03, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 449,832 |
Ending reported balance
After 2026-09-01 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-09-01 · Sale · Disposed 2,213 · Balance 455,498 F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026. Row 2 · 2026-09-01 · Sale · Disposed 2,390 · Balance 453,108 F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025. Row 3 · 2026-09-01 · Sale · Disposed 1,530 · Balance 451,578 F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024. Row 4 · 2026-09-01 · Sale · Disposed 1,746 · Balance 449,832 F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on March 2, 2026.
F2: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 3, 2025.
F3: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2024.
F4: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 753 | $9.06 | $6,822.18 |
DisclosureSEC source: 0001415889-24-006846 · form4-03052024_110331.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,868 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 428 | $9.06 | $3,877.68 |
DisclosureSEC source: 0001415889-24-006846 · form4-03052024_110331.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 242,621 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 01:02 UTC Amendment | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 34,500 | $0.00 Strike: $9.30 | $0.00 |
DisclosureSEC source: 0001415889-24-007234 · form4a-03082024_010315.xml · derivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,500 Underlying: Common Stock · 34,500 shares Expires 2034-02-28 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2024. Read SEC document |
| March 01, 2024 Filed Mar 8, 2024 01:02 UTC Amendment | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 69,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-007234 · form4a-03082024_010315.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 309,052 F1 · shares: Represents grant of RSUs payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2024. Read SEC document |
| February 22, 2024 Filed Feb 26, 2024 23:23 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $14.20 | $16,812.80 |
DisclosureSEC source: 0001415889-24-005309 · form4-02262024_110219.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 243,049 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| January 22, 2024 Filed Jan 24, 2024 22:41 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $13.13 | $15,545.92 |
DisclosureSEC source: 0001415889-24-001766 · form4-01242024_100127.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · CHIEF COMMERCIAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 244,233 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| December 22, 2023 Filed Dec 27, 2023 21:19 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $12.75 | $15,096.00 |
DisclosureSEC source: 0001209191-23-059779 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 245,417 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,774 | $10.34 | $18,343.16 |
DisclosureSEC source: 0001209191-23-057512 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,601 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 698 | $10.34 | $7,217.32 |
DisclosureSEC source: 0001209191-23-057512 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 248,375 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| December 01, 2023 Filed Dec 5, 2023 22:46 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 396 | $10.34 | $4,094.64 |
DisclosureSEC source: 0001209191-23-057512 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 249,073 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 23:14 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $10.60 | $12,550.40 |
DisclosureSEC source: 0001209191-23-056719 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 249,469 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| October 23, 2023 Filed Oct 25, 2023 22:20 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $8.35 | $9,886.40 |
DisclosureSEC source: 0001209191-23-053594 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 250,653 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| September 22, 2023 Filed Sep 26, 2023 22:15 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $10.51 | $12,443.84 |
DisclosureSEC source: 0001209191-23-050608 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 251,837 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:03 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,759 | $10.01 | $17,607.59 |
DisclosureSEC source: 0001209191-23-048511 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 253,021 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:03 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 691 | $10.01 | $6,916.91 |
DisclosureSEC source: 0001209191-23-048511 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 254,780 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| September 01, 2023 Filed Sep 6, 2023 22:03 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 393 | $10.01 | $3,933.93 |
DisclosureSEC source: 0001209191-23-048511 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 255,471 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| August 23, 2023 Filed Aug 25, 2023 21:40 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,184 | $10.54 | $12,479.36 |
DisclosureSEC source: 0001209191-23-047388 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 255,864 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 24, 2023. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:47 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 1,760 | $11.48 | $20,204.80 |
DisclosureSEC source: 0001209191-23-034007 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 257,048 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2023. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:47 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 692 | $11.48 | $7,944.16 |
DisclosureSEC source: 0001209191-23-034007 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 258,808 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the RSUs granted on March 1, 2022. Read SEC document |
| June 01, 2023 Filed Jun 2, 2023 22:47 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 393 | $11.48 | $4,511.64 |
DisclosureSEC source: 0001209191-23-034007 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 259,500 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (the "RSUs") granted on June 1, 2021. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:02 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 54,000 | $0.00 Strike: $11.48 | $0.00 |
DisclosureSEC source: 0001209191-23-016021 · doc4.xml · derivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 54,000 shares Expires 2033-02-28 F5 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:02 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 78,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-016021 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,893 F4 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2023. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 769 | $11.03 | $8,482.07 |
DisclosureSEC source: 0001209191-23-016021 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,993 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| March 01, 2023 Filed Mar 4, 2023 00:02 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 437 | $11.03 | $4,820.11 |
DisclosureSEC source: 0001209191-23-016021 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,762 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. F2 · balance_after: Includes 1,162 shares acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2023. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 23:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 673 | $5.93 | $3,990.89 |
DisclosureSEC source: 0001209191-22-059852 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,037 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 23:58 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 382 | $5.93 | $2,265.26 |
DisclosureSEC source: 0001209191-22-059852 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,710 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:52 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 655 | $17.90 | $11,724.50 |
DisclosureSEC source: 0001209191-22-048782 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,092 F3 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| September 01, 2022 Filed Sep 6, 2022 20:52 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 372 | $17.87 | $6,647.64 |
DisclosureSEC source: 0001209191-22-048782 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 182,747 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. F2 · balance_after: Includes 1 share acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:12 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 645 | $18.05 | $11,642.25 |
DisclosureSEC source: 0001209191-22-034317 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,118 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 1, 2022. Read SEC document |
| June 01, 2022 Filed Jun 3, 2022 22:12 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 366 | $18.05 | $6,606.30 |
DisclosureSEC source: 0001209191-22-034317 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 183,763 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 23:06 UTC | Pulmonx Corp LUNG · Entity 2359 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,427 | $0.00 Strike: $2.10 | $0.00 |
DisclosureSEC source: 0001209191-22-018263 · doc4.xml · derivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,192 Underlying: Common Stock · 29,427 shares Expires 2029-10-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The shares subject to the option are immediately exercisable and vest in 48 equal monthly installments beginning on October 2, 2019, subject to the Reporting Person's continuous service through each such vesting date. Read SEC document |
| March 10, 2022 Filed Mar 11, 2022 23:06 UTC | Pulmonx Corp LUNG · Entity 2359 | Exercise / conversionCommon Stock | 29,427 | $2.10 | $61,796.70 |
DisclosureSEC source: 0001209191-22-018263 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,129 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:13 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 68,700 | $0.00 Strike: $26.56 | $0.00 |
DisclosureSEC source: 0001209191-22-015836 · doc4.xml · derivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,700 Underlying: Common Stock · 68,700 shares Expires 2032-02-29 F4 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:13 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 31,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-015836 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,702 F3 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on March 1, 2022. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 23:13 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 426 | $25.91 | $11,037.66 |
DisclosureSEC source: 0001209191-22-015836 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,702 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. F2 · balance_after: Includes 669 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on February 15, 2022. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 360 | $31.48 | $11,332.80 |
DisclosureSEC source: 0001209191-21-070066 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,459 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.36 to $31.58, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 15, 2021 Filed Dec 16, 2021 23:22 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 21,640 | $30.53 | $660,669.20 |
DisclosureSEC source: 0001209191-21-070066 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,819 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.335 to $31.33, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| December 01, 2021 Filed Dec 3, 2021 23:39 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 355 | $32.73 | $11,619.15 |
DisclosureSEC source: 0001209191-21-067971 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,459 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. Read SEC document |
| November 15, 2021 Filed Nov 16, 2021 23:09 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 7,000 | $39.94 | $279,580.00 |
DisclosureSEC source: 0001209191-21-064854 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.83 to $40.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 7,000 | $39.44 | $276,080.00 |
DisclosureSEC source: 0001209191-21-060779 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.001 to $40.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 15, 2021 Filed Sep 17, 2021 22:42 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 7,000 | $38.12 | $266,840.00 |
DisclosureSEC source: 0001209191-21-056727 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,814 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.50 to $38.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 21:55 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 355 | $40.09 | $14,231.95 |
DisclosureSEC source: 0001209191-21-054860 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,814 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 1, 2021. F2 · balance_after: Includes 284 shares acquired by the reporting person under the Issuer's 2020 Employee Stock Purchase Plan on August 13, 2021. Read SEC document |
| August 16, 2021 Filed Aug 19, 2021 00:09 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 7,000 | $36.71 | $256,970.00 |
DisclosureSEC source: 0001209191-21-052427 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.39 to $37.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 100 | $39.24 | $3,924.00 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,885 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 6,142 | $38.86 | $238,678.12 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 173,985 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.20 to $39.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:49 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 758 | $37.57 | $28,478.06 |
DisclosureSEC source: 0001209191-21-047262 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,127 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $38.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:22 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantEmployee Stock Option (right to buy) · Derivative | 39,900 | $0.00 Strike: $43.40 | $0.00 |
DisclosureSEC source: 0001209191-21-040076 · doc4.xml · derivative · entry 2 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,900 Underlying: Common Stock · 39,900 shares Expires 2031-05-31 F2 · derivative.exercise_date: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021. Read SEC document |
| June 01, 2021 Filed Jun 12, 2021 00:22 UTC | Pulmonx Corp LUNG · Entity 2359 | GrantCommon Stock | 17,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-040076 · doc4.xml · nonDerivative · entry 1 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,885 F1 · shares: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 400 | $41.55 | $16,620.00 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 4 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,285 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
| May 24, 2021 Filed May 25, 2021 21:18 UTC | Pulmonx Corp LUNG · Entity 2359 | SaleCommon Stock | 10 | $41.52 | $415.20 |
DisclosureSEC source: 0001209191-21-035741 · doc4.xml · nonDerivative · entry 3 Rose Geoffrey Beran · CIK 0001804146 · Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,685 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 14, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.